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Continuous single cell imaging 
reveals sequential steps of 
plasmacytoid dendritic cell 
development from common 
dendritic cell progenitors
Ezgi Dursun1, Max Endele2, Andrea Musumeci1, Henrik Failmezger3,4, Shu-Hung Wang1, 
Achim Tresch3,4, Timm Schroeder2 & Anne B. Krug1
Functionally distinct plasmacytoid and conventional dendritic cells (pDC and cDC) shape innate and 
adaptive immunity. They are derived from common dendritic cell progenitors (CDPs) in the murine bone 
marrow, which give rise to CD11c+ MHCII− precursors with early commitment to DC subpopulations. In 
this study, we dissect pDC development from CDP into an ordered sequence of differentiation events 
by monitoring the expression of CD11c, MHC class II, Siglec H and CCR9 in CDP cultures by continuous 
single cell imaging and tracking. Analysis of CDP genealogies revealed a stepwise differentiation 
of CDPs into pDCs in a part of the CDP colonies. This developmental pathway involved an early 
CD11c+ SiglecH− pre-DC stage and a Siglec H+ CCR9low precursor stage, which was followed rapidly 
by upregulation of CCR9 indicating final pDC differentiation. In the majority of the remaining CDP 
pedigrees however the Siglec H+ CCR9low precursor state was maintained for several generations. Thus, 
although a fraction of CDPs transits through precursor stages rapidly to give rise to a first wave of pDCs, 
the majority of CDP progeny differentiate more slowly and give rise to longer lived precursor cells which 
are poised to differentiate on demand.
Clinical and animal studies provide evidence for an important role of plasmacytoid dendritic cells (pDCs) in 
innate antiviral defense, systemic and tissue-specific autoimmunity1–3 and immunopathology during chronic 
viral infection4 involving their capacity to secrete high amounts of type I interferons (IFNs). Furthermore, pDCs 
were shown to promote immune tolerance preventing neuroinflammation5,6 and graft versus host disease after 
allogeneic bone marrow (BM) transplantation7,8.
PDC and conventional DC subpopulations are derived from the common dendritic cell progenitor (CDP) 
population in murine and human BM. PDCs develop from CDP in the BM9,10 and are retained there at a higher 
frequency than cDCs, which derive from circulating cDC precursors (pre-cDCs)11,12. Generation of DC sub-
populations is not confined to the CD115+ CDP population as CD115− DC progenitor cells in murine BM were 
also shown to give rise to all DC subtypes with a bias towards pDC generation13. PDC development is driven by 
transcription factor E-protein E2-2/Tcf4, which in turn is controlled by inhibitor of DNA binding 2 (Id2)14,15. 
Conversely, E2-2 acts in concert with Myeloid translocation gene 16 (Mtg16) and other factors such as Zeb216 
to repress Id2, allowing final pDC differentiation17. Several pDC subpopulations have been identified in murine 
BM and spleen18–22 as well as in human blood23–27, which are distinct in phenotype and function. It remains to be 
elucidated whether these subpopulations represent sequential stages of differentiation and maturation or whether 
they develop independently of each other. We have previously identified a population of Siglec H+ CCR9low pre-
cursors in murine BM, which resembles pDCs in phenotype and function. In contrast to pDCs, however, those 
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cells have the capacity to generate mature pDCs or cDC subsets in the steady state depending on the environ-
mental cues provided in different tissues22,28. This population is characterized by expression of CD11c, Siglec 
H and BST2 and low expression of CCR9, B220 and MHCII. The Siglec H+ CCR9low precursors express E2-2 
and produce type I IFNs and other cytokines in response to toll-like receptor (TLR) 7 and 9 stimulation similar 
to CCR9high pDCs, but they are not yet capable of presenting antigens on MHC class II29. Other groups have 
described Siglec H+ pre-DCs, which partially express Zbtb46 and give rise to pDCs and cDC subtypes30,31. This 
population was shown to be enriched in the BM of Mtg16-deficient mice due to aberrant Id2 induction in these 
cells blocking pDC development17. Recent work suggested that Siglec H+ pre-DCs are derived from CDPs and 
constitute an early pre-DC stage which gives rise to pDCs and pre-cDCs17,31. It was unclear so far, if the Siglec H+ 
CCR9low population truly is a CDP-derived precursor of pDCs or if it develops in parallel as an immature subset 
of pDCs. To clearly delineate the ontogeny and cell fate of this pDC-like precursor population and to understand 
the extent of lineage commitment at the CDP and pre-DC stages, we chose to study the development of individual 
CDP progeny in vitro by single cell imaging and tracking32. This approach allowed us to correlate cell division 
behaviour and acquisition of cell type defining markers in CDP progeny. Time series analysis elucidated the rela-
tionship between cell types, thereby refining the model of differentiation events from CDPs to mature DCs. Using 
this method, we could show that pDCs develop from CDPs sequentially via intermediate stages of early CD11c+ 
SiglecH− pre-DC and SiglecH+ CCR9low precursors.
Results
Continuous long-term observation of individual dendritic cell progenitors and their progeny. 
Common DC progenitors (CDP) isolated from murine BM cells give rise to DC subpopulations including pDC 
and cDCs in culture with Flt3L and feeder cells or in vivo after adoptive transfer. Recent studies indicate that CDP 
give rise to CD11c+ MHCII− pre-DC populations, which are biased to differentiate into specific DC subpopula-
tions. The precise steps of pDC and cDC development from the CDP and the relationship between individual pro-
genitor, precursor and differentiated cells are not known. To reveal the genealogy of the DC lineage and identify 
sequential steps of pDC development, CDP and their progeny were continuously imaged and tracked. To reduce 
the heterogeneity of the CDP population CD115− DC progenitor cells13 were excluded (Supplementary Fig. 1). 
A co-culture system was established which allows distinction of CDP and their progeny from the feeder cell layer 
by morphology. The embryonic liver (EL) 08 stromal cell line supported CDP expansion and differentiation into 
pDCs and cDCs in the presence of Flt3L similar to total BM feeder cells (Supplementary Fig. 2). For continuous 
imaging, sorted CDP were cultured on EL08 monolayers with Flt3L in μ -slides for 5 days. Acquisition of CD11c, 
MHC II, Siglec H and CCR9 expression was detected by continuous in culture staining33. Addition of diluted flu-
orescently labeled antibodies during FL-DC cultures did not affect the phenotype and frequency of DC subsets, 
which were generated (Fig. 1A). The sensitivity of the fluorescence imaging was sufficient to detect all markers 
and to distinguish CCR9high pDCs (e.g. cell no. 1) from SiglecH+ CCR9low cells (e.g. cell no. 2) (Fig. 1B). CDP 
pedigrees with annotation of the fluorescent markers (off, on or high) were generated by single cell tracking 
(Supplementary Fig. 3) from different imaging positions (exp. 1: 40 annotated pedigrees, containing 676 cells; 
exp. 2: 45 pedigrees containing 1371 cells). Apoptosis occurred in only 3.7% and 0.9% of the cells and 17.2% and 
16.6% of the CDP progeny were lost to tracking due to movement outside of the imaging position or migration 
under the stromal cell layer (data from exp. 1 and exp. 2, respectively, data not shown). Within the remaining 
non-apoptotic and not-lost cells, over 50% were dividing during the experiment time (exp. 1: 56.8%, exp. 2: 58%, 
data not shown) and up to 8 generations could be observed. Thus, continuous imaging of CDP in the EL08/Flt3L 
co-culture system allows the generation of CDP genealogies, which reveal heterogeneous behaviour of CDP prog-
eny with regard to number of divisions and acquisition of cell type defining markers.
Sequential development of pDCs via distinct precursor stages. The frequency of all possible marker 
combinations was determined for all cells within the pedigrees occurring during the 120 hours of experiment 
time. SiglecH+ CCR9low precursor cells with the annotation CCR9 on, CD11c on, Siglec H on, MHCII on or 
off were the most frequent cell type observed (51.2%, Fig. 2A and B). These cells contained a small percentage 
of cells with higher intensity of the Siglec H signal (4.2% of SiglecH+ CCR9low), which was due to intracellular 
accumulation of the Siglec H antibody or upregulation of Siglec H expression. The second most frequent cell 
types were early pre-DC (CD11c on, CCR9 on or off, Siglec H off, MHCII off, 13.9%) and CCR9high pDCs (CCR9 
high, CD11c on, Siglec H on or high, MHCII on or off, 14%). CDP (all markers off, 7.8%) and cells with cDC or 
pre-cDC phenotype (CCR9 on or off, CD11c on, Siglec H off, MHCII on, 5.1%) were detected at lower frequen-
cies. A clear distinction between pre-cDCs and cDCs was not possible because MHCII can already be expressed 
at low levels in pre-cDCs. While the CDP population was rapidly declining, the pre-DC population increased 
with a peak at approximately 30 hours (Fig. 2B). The number of pre-DCs decreased thereafter concomitant with 
an increase in the SiglecH+ CCR9low precursor population, which was followed immediately by an expansion of 
the pDC population. cDCs/pre-cDCs appeared quite early together with the SiglecH+ CCR9low precursors and the 
population was maintained thereafter (Fig. 2B). The sequential appearance of the different populations indicates 
progressive development of the CDP progeny via distinct precursor stages.
Analysis of the time of onset of the marker expression in the pedigrees showed that CD11c was the earliest 
marker to be expressed (median 22.5 hrs), followed by CCR9 (40.9 hrs), Siglec H (45.1 hrs) and then MHC class 
II (53.6 hrs) (Fig. 3A). The onset of high signal intensity of CCR9 and Siglec H occurred later in the pedigrees 
(median 54.3 and 71.3 hrs respectively) (data not shown). The sequence of time of onset of CD11c, CCR9 and 
SiglecH was confirmed in a second experiment (Supplementary Fig. 4A,B). The time until occurrence of the 
different cell populations defined by marker combinations was calculated as the weighted average of the indi-
vidual waiting times within each pedigree. The median time to event was shortest for pre-DCs (22 hrs) followed 
by SiglecH+ CCR9low precursors (51 hrs) and then pDCs (58 hrs). The first appearance of (pre)-cDCs (CD11c+ 
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MHCII+ Siglec H− cells) was observed later than that of pre-DCs, but earlier than that of pDCs (40 hrs). The 
small subset of SiglecHhigh CCR9low cells appeared at later time points (88 hrs) (Fig. 3B). From these results we 
conclude, that on a population basis CD11c+ MHCII− Siglec H− early pre-DCs precede SiglecH+ CCR9low cells 
which are followed by CCR9high pDCs shortly thereafter. Cell phenotypes were inherited by the daughter cells in 
most cases, but at later time points acquisition of additional markers by the daughter cells was not synchronized 
and quite heterogeneous.
Direct transition between cell types was analysed in the pedigrees (see example shown in Fig. 4A). The num-
ber of transitions between cell types in all pedigrees were counted (Fig. 4B, Supplementary Table 1). Transitions 
between CDP and pre-DC and between pre-DC and SiglecH+ CCR9low cells were observed frequently. 
Simultaneous acquisition of CD11c, CCR9 and SiglecH signals (SiglecH+ CCR9low cell phenotype) was observed 
(e.g. Fig. 4A. cell no. 6 and 29), but the most frequent transition to SiglecH+ CCR9low cells was from pre-DCs 
(CD11c+ CCR9− or CCR9+ phenotype). In the majority of the cases CCR9high pDCs developed from SiglecH+ 
CCR9low cells (exp. 1: 87%, Fig. 4B; exp. 2: 65%). Direct acquisition of the pDC phenotype by CDP or pre-DC 
was also observed (e.g. Fig. 4A, cell no. 28). Although the high CCR9 signal was transmitted to the daughter cells 
Figure 1. Identification of cell types by in culture staining. (A) Total BM cells were cultured either 
with fluorescently labeled antibodies against SiglecH, CCR9, CD11c and MHCII or without antibodies 
in the presence of 20 ng/ml Flt3L for 5 days. After 5 days, cells were stained freshly with fluorescently 
labeled antibodies against SiglecH, CCR9, CD11c, MHCII and B220. The percentages of pDCs, cDCs and 
SiglecH+ CCR9high and SiglecH+ CCR9low subpopulations were determined by FACS analysis. Results of one 
representative of 2 experiments are shown. (B) CDPs were cultured on EL08 feeder cells with 20 ng/ml Flt3L for 
5 days. Fluorescently labeled antibodies against Siglec H, CCR9, CD11c and MHCII were added at the start of 
the experiment. Exemplary phase contrast and fluorescence images of indicated cells are shown.
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(e.g. Fig. 4A cells no. 22, 23, 28), it was not always maintained at high levels in pDCs until the end of the exper-
iment. Calculation of the transition times between cell types (Fig. 4C) revealed that transition from SiglecH+ 
CCR9low precursors to CCR9high pDCs was rapid (median/IQR: 16/15 hrs) compared to the transition from CDP 
and pre-DC to SiglecH+ CCR9low precursors (median/IQR: 28/39hrs and 35/32 hrs respectively). Taken together 
our results show that a part of the CDPs were able to give rise to pDCs within 3 days of culture and in the majority 
of these cases CDP progeny transited sequentially through pre-DC and SiglecH+ CCR9low intermediate precursor 
stages of variable duration before differentiating into pDCs.
Heterogeneous behaviour of CDP progeny regarding number of generations and cell fate. 
Evaluation of the pedigrees revealed that CDP were heterogeneous in the number of generations and colony size 
they produced. After exclusion of nine pedigrees, in which many of the cells could not be observed until the end 
of the experiment, the median number of generations in the pedigrees was 4 (IQR 2) and the median colony size 
was 19 cells (IQR 16, n = 31). From the third generation onwards, sibling cells and their progeny showed highly 
heterogeneous behaviour regarding cell life time and number of divisions (see Figs 4A and 5A–D).
CDP and their progeny were also heterogeneous with regard to the cell fate they reached during the experi-
ment time (Fig. 5E, Supplementary Fig. 4). In approximately one third of the pedigrees (exp. 1: 27.5%, exp. 2: 36. 
%) a pDC cell fate was observed, including pedigrees in which both pDC and CCR9low precursor cells were found 
Figure 2. Sequential appearance of cell types in CDP cultures. (A) Frequency of marker combinations. Each 
marker can have 3 states, according to its expression level: off (black), on (grey) or high (white). Each cell is 
counted once, with its marker combination observed immediately before cell division. (B) Marker combinations 
were grouped manually into distinct cell types (right panel). The relative frequency of each cell type is shown for 
each time point.
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at the end of the experiments (examples shown in Figs 4A and 5A). In a considerable number of pedigrees CDP 
generated Siglec H+ CCR9low precursors, but not CCR9high pDCs (exp.1: 57.5%, exp. 2: 33%; examples shown in 
Fig. 5B and C). In these cases the Siglec H+ CCR9low precursor state was maintained until the end of the obser-
vation time. In a minority of the pedigrees, CD11c+ Siglec H− MHCII+ (pre)-cDC were observed as final cell 
phenotype including pedigrees with additional generation of SiglecH+ CCR9low precursors (exp. 1: 10%, exp. 
2: 9%; example shown in Fig. 5D). The percentage of pedigrees, which maintained an undifferentiated pheno-
type (expressing only CD11c and/or CCR9) varied between experiments (exp.: 5%, exp. 2: 22%). Generation 
of cDC/pre-cDC and CCR9high pDCs from the same CDP was not observed during the experiment time, sug-
gesting that CDP were already precommitted to the pDC or cDC lineage. Taken together, cell fate analysis in 
CDP genealogies showed that rapid differentiation into pDCs occurred in a part of the colonies, whereas the 
CD11c+ SiglecH+ CCR9low phenotype was maintained for several generations in the majority of the remaining 
colonies. To investigate the differentiation potential of SiglecH+ CCR9low precursors in our culture conditions 
SiglecH+ CCR9low cells and CCR9high pDCs were sorted from primary BM cells and their phenotype was ana-
lyzed by flow cytometry after 48 hrs of coculture with EL08 cells in the presence of Flt3L or Flt3L and GM-CSF 
(see Supplementary Fig. 5). The majority of SiglecH+ CCR9low precursors upregulated CCR9 confirming that they 
can differentiate into pDCs under steady state conditions. Addition of GM-CSF to the culture prevented pDC 
differentiation in a part of these cells, while the other part of this population was committed to generate CCR9high 
pDCs. However the phenotype of CCR9high pDCs (sorted from primary BM cells) was not changed under these 
conditions (Supplementary Fig. 5).
A higher number of generations was observed in pedigrees, which generated pDCs during the experiment 
time, compared to pedigrees which generated only Siglec H+ CCR9low cells (median 5 vs. 3.5, p = 0.0055, Fig. 6A 
and B). A similar trend towards a higher number of generations in CDP colonies with pDC fate was observed 
in a second independent experiment (Supplementary Fig. 4). In all pedigrees with pDC development, pDCs 
continued to divide. The median cell lifetime of dividing cells was similar for pedigrees with pDC generation and 
Figure 3. Time-dependent occurrence of cell types in CDP genealogies. CDPs were cultured on EL08  
feeder cells with Flt3L for 5 days and their progeny were observed continuously by single cell imaging and 
tracking. (A) The time until first occurrence of fluorescent markers in the pedigrees was determined. (B) The 
time until first occurrence of each cell type in the pedigrees was calculated as weighted mean. Data are shown 
as box plots with whiskers and outliers, median values indicated by horizontal lines. Significant differences are 
indicated by an asterisk (p < 0.05, Kruskall-Wallis-test with Dunn’s post test).
www.nature.com/scientificreports/
6Scientific RepoRts | 6:37462 | DOI: 10.1038/srep37462
for pedigrees, which generated only CCR9low precursors (22.0 vs. 21.5 hrs, Fig. 6C). Our results suggest that CDP 
differ with regard to speed of differentiation. Thereby a pool of precursor cells, which is not yet fully committed, 
can be generated alongside the differentiated cells providing flexibility to the system.
Discussion
In this study we used for the first time the method of continuous single cell imaging and tracking to observe the 
sequential development of DCs from individual progenitor cells over time. This method has been previously used 
to investigate the differentiation of embryonic and adult stem cells34,35, hematopoietic progenitors32,36 and cancer 
cells37. Using the CDP/EL08/Flt3L culture system, DC development could be observed continuously at the single 
cell level for 5 days without disturbing the culture. The in-culture staining technique was used to follow the onset 
of expression of cell type defining surface markers without influencing the phenotype and frequency of the cell 
types generated in the culture system. This method has been used previously to track the expression of surface 
markers on hematopoietic cells developing from haemogenic endothelial cells38. It allows the detection of onset 
of marker expression, whereas the detection of downregulation of surface marker expression may be confounded 
by antibody internalization. Signals due to intracellular accumulation of antibodies would be expected to decrease 
Figure 4. Frequency and duration of transitions between cell types. (A) A representative pedigree of a single 
CDP and its progeny. Branches are colored according to cell type (see Fig. 4B). Apoptotic events are marked 
with X whereas cell losses are indicated by a question mark. (B) Cell type transition graph. Nodes represent 
cell types defined by marker combinations. The colour code and assigned marker combinations are shown for 
each cell type on the right. The number of observed transitions between two cell types defines the width of the 
connecting arrow. Transitions occurring less than 10 times were omitted. (C) Median waiting time spent by 
cell type x (rows) until transformation into cell type y (columns). Infrequent transitions (observed less than 10 
times) and the main diagonal are greyed out.
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by distribution to the daughter cells. However, signal intensity was not reduced after division demonstrating 
accurate detection of surface marker expression by this method. Furthermore, cells, which were labeled positively 
for Siglec H and showed intracellular signal, did not lose Siglec H surface expression during the experiment time. 
Thus, in culture staining accurately detects surface marker combinations, which define cell types developing in 
CDP cultures. In this study we followed the transitions between different precursor and differentiated cell types 
that were defined a priori by the expression pattern of four different cell surface markers. The de novo definition 
of cell types from time lapse images has recently attracted some interest39,40. However, the numerous cell divisions 
Figure 5. Heterogeneity of CDP division kinetic and cell fate. CDP and their progeny were monitored 
by time-lapse microscopy and single cell tracking. Cell divisions and fluorescent signals were annotated in 
pedigrees. Pedigrees were segregated according to their cell fate. Examples of pedigrees with pDC and SiglecH+ 
CCR9low fate (A), with only SiglecH+ CCR9low fate (B,C) or with SiglecH+ CCR9low and cDC fate (D) are shown. 
(E) The pie chart shows the percentages of pedigrees, in which generation of pDCs or cDCs occurred, in which 
SiglecH+ CCR9low precursor cells were generated without occurrence of pDCs or cDCs, and, in which only cells 
with CDP or pre-DC phenotype were generated (undifferentiated).
www.nature.com/scientificreports/
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in our data create large trees, which require extending the commonly used hidden Markov models to tree-shaped 
structures (Failmezger et al., submitted manuscript). This will yield an unsupervised classification of cells accord-
ing to surface marker combinations and other phenotypic features.
Our single cell tracking results showed that CDPs gave rise to early CD11c+ SiglecH− pre-DCs and then devel-
oped into Siglec H+ CCR9low precursors. In a subset of CDP colonies, Siglec H+ CCR9low precursors rapidly gave 
rise to CCR9high pDCs, which continued to expand. At the same time, CDP colonies with delayed differentiation 
produced Siglec H+ CCR9low precursors, which maintained this phenotype until the end of the experiments. 
These cells constitute a sizable population in the BM and contain cells which are poised to differentiate into pDCs 
as shown previously22,28. This may be beneficial in the setting of viral infection when pDCs are depleted and need 
to be replenished rapidly41,42. Thus, pDC frequency is regulated at the level of proliferation of pDCs in the BM 
and at the level of differentiation of SiglecH+ CCR9low precursors. In vivo pDC numbers are additionally regu-
lated by pDC release from BM into the blood and recruitment to lymphoid and non-lymphoid organs, which are 
controlled by expression of transcription factor Runx2 in pDCs43,44. CDC numbers were shown to be regulated by 
release and recruitment of pre-cDCs and local expansion45.
Our finding, that Siglec H+ CCR9low precursors were generated from SiglecH− pre-DCs is seemingly contra-
dictory to published results, which suggest that Siglec H− pre-DCs are derived from Siglec H+ pre−DCs and have 
lost pDC potential30,31. The SiglecH− CD11c+ MHCII− precursors, which we have observed as an intermediary 
cell type, occurring at early time points in CDP cultures, are not identical to the SiglecH− pre-DC populations 
found in the primary BM31. In our experiments the onset of CD11c expression clearly preceded the onset of Siglec 
Figure 6. Number of divisions correlates with differentiation stage. (A) CDPs were cultured on EL08 stromal 
cells for 5 days and progenies of the CDP were tracked continuously. Pedigrees were segregated according 
to their cell fates. The numbers of generations in each pedigree are shown as symbols (CCR9high pDC fate, 
n = 11 vs. only Siglec H+ CCR9low precursor fate, n = 18). Median numbers of generations are indicated by 
lines. *p = 0.0055, unpaired t-test. (B) The numbers of pedigrees with the indicated number of generations are 
shown for pedigrees with CCR9high pDC fate (white columns) and only Siglec H+ CCR9low precursor fate (grey 
columns). (C) The cell life times of all dividing cells in pedigrees with CCR9high pDC fate (n = 153 cells) and 
Siglec H+ CCR9low precursor fate (n = 134 cells) are shown (ns: not significant, unpaired t-test).
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H expression and we found no evidence for downregulation of Siglec H at later time-points, although Siglec H 
antibody internalization may have masked downregulation of Siglec H expression in our study.
Colonies in which pDCs were generated contained on average more generations, suggesting that division 
speed and differentiation are connected. But CDPs and even siblings within the same CDP colony were quite 
heterogeneous regarding division kinetic and cell fate. PDC differentiation was seen alongside SiglecH+ CCR9low 
precursor development in the same pedigrees, showing that CDP colonies as a whole, but also branches within 
the same CDP colony can differentiate at a different pace and give rise to different developmental stages at the 
same time point. Even though we excluded the recently described pDC-biased CD115− DC progenitor cells13 and 
restricted our analysis to CD115+ CDPs, which show quite homogeneous surface marker expression, single cell 
tracking revealed the diversity of this population. The heterogeneous behaviour of CDPs and pre-DCs observed 
in our study is in line with results of clonal assays where only a minority of CDPs gave rise to all DC subtypes12,13 
and with single cell transcriptome data showing great heterogeneity on the gene expression level in DC progenitor 
cells31. The single cell imaging and tracking approach allowed us to identify CDP subpopulations with defined 
characteristics. Similarly, clusters of CDPs and pre-DCs with common gene expression signatures indicating DC 
subtype priming were identified by single cell transcriptome analysis31. Distinct behaviour and cell fate of progen-
itor and precursor subsets are either intrinsically predetermined or caused by differential responses to extrinsic 
factors, such as growth factors and cell contact dependent signals. In the present study, contact with stromal cells 
and with developing DCs may have influenced the behaviour of individual CDP and their progeny. The situation 
in vivo is similar as hematopoiesis including DC development occurs in BM niches. The culture system used here 
mimics this situation, but cannot recapitulate the complexity of DC development in the BM in vivo. Nevertheless, 
the heterogeneous behaviour of DC progenitors found in our study was also seen in vivo in a study that followed 
the cell fates of individual progenitor cells marked with heritable DNA barcodes46. Our results are in line with the 
model of early lineage branching in myelopoeisis that is supported by recent publications employing single cell 
transcriptome analysis and single cell lineage tracing47,48.
This is the first study, which continuously follows individual DC progenitor cells during their development 
into functionally distinct DC subpopulations. Our results show that the behaviour of committed DC progenitor 
cells with regard to division kinetics and acquisition of cell type defining markers is more heterogeneous than 
previously thought, allowing for plasticity until late steps of development.
Methods
Mice. C57BL/6 and CD45.1-congenic mice were bred in our facility under specific pathogen free conditions. 
All experimental procedures involving mice were performed in accordance with the regulations of and were 
approved by the local government (Regierung von Oberbayern).
Cell isolation and culture. BM cells were isolated from femora and tibiae of 6–8 weeks old mice. After red 
blood cell lysis (RBC Lysis Buffer, Sigma-Aldrich, St. Louis, MO, USA) cells were washed and resuspended in den-
dritic dell (DC) medium containing RPMI 1640, (Biochrom, Berlin, Germany), 10% (v/v) heat-inactivated fetal calf 
serum (PAA, Austria), 1% (v/v) non-essential amino acids (PAA), 1% (v/v) Glutamax (Thermo Fisher Scientific, 
Waltham, MA, USA), 1% (v/v) Sodium Pyruvate (100 mM, Thermo Fisher Scientific), 1% (v/v) penicillin/strep-
tomycin (PAA), 0.05 mM β -mercaptoethanol (Sigma-Aldrich, Germany) and supplemented with 20 ng/mL 
Flt3L (purified from supernatant of CHO-flk2 cell line kindly provided by Nicos Nicola, Walter and Eliza Hall 
Institute). Cells were cultured for 5 days at 37 °C in 5% CO2 to obtain FL-DCs.
Live cell imaging experiments were performed using the embryonic liver (EL) 08 stromal cell line as feeder 
cells49. EL08 cells were cultured in EL08 medium (MEM-α -Glutamax (Invitrogen, Karlsruhe, Germany), 15% v/v 
heat inactivated fetal calf serum, 5% v/v horse serum (Stem Cell Technologies, Köln, Germany), 1% penicillin/
streptomycin, 0.01 mM β -mercaptoethanol) at a density of 5*105/ml in 10 cm dishes coated with 0.1% gelatin 
(Sigma Aldrich, Seelze, Germany) as described before49. After 2–3 days of expansion, cells were detached using 
Trypsin/EDTA (Thermo Fisher Scientific), resuspended in EL08 medium and seeded in ibidi μ -slides (Ibidi, 
Martinsried, Germany) for imaging experiments.
Flow Cytometry and cell sorting. For isolation of CDPs, lineage-positive cells were depleted from BM 
cells by staining with FITC-conjugated antibodies against CD3, CD19, B220, Gr1, NK1.1 and CD11b in FACS 
buffer (PBS containing 2% FCS) and separation using anti-FITC microbeads (Miltenyi Biotech, Germany). 
Lineage-depleted cells were stained with FITC-conjugated antibodies against CD3, CD19, B220, Gr-1, NK1.1 
(BD Biosciences), CD11b (eBioscience) and with anti-CD135-PE, anti-CD11c-PE-Cy7, anti-CD115-APC, 
anti-CD117-eFlour780 and anti-MHCII-eFlour450 (eBioscience) in FACS buffer (PBS, 2% FCS) containing 50% 
supernatant of 2.4G2 hybrioma (Fc block) for 20 min on ice. To exclude dead cells from the analysis, propid-
ium ioidide (2.5 μ g/ml) was added to each sample just prior to FACS analysis. CDPs were sorted as Lin− Flt3+ 
CD117low CD115+ CD11c− MHCII− cells to high purity using FACS Aria III (BD Biosciences), as shown in 
supplementary Fig. 1. FACS analysis of DC cultures was performed using anti-CD45.1-Pe-Cy5.5, anti-CCR9-PE, 
anti-CD11c-Pe-Cy7, anti-MHCII-eFluor780 (eBioscience), anti-CD45.2-eFluor450, anti-B220-BV605 (BD 
Biosciences) anti-SiglecH-A488 and anti-SiglecH-A647 (produced in our lab from 440c hybridoma, kindly pro-
vided by Marco Colonna, Washington University, St. Louis, USA). Samples were acquired on a FACS Gallios or 
Cytoflex flow cytometer (Beckman Coulter, Krefeld, Germany) and analysed using FlowJo software (Tree Star, 
Stanford, USA).
Live cell imaging and long-term antibody staining of CDP cultures. Prior to imaging, μ -slides (I0.4 Luer 
Series, uncoated, Ibidi) were coated with 0.1% gelatin and EL08 stromal cells (2*104 cells in 100 μ l EL08 medium) 
were seeded. Within 24 hours, when stromal cells had reached 40–50% optical confluence, the medium was removed 
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and 2*103 CDPs per slide were seeded in DC medium containing 20 ng/ml Flt3L for live cell imaging experiments. 
Higher concentrations of Flt3L had no major effect on DC subtype differentiation but increased cell density 
(data not shown) and were therefore less suitable for single cell tracking. Fluorescently labeled antibodies were 
added for in culture staining as described before38. Antibodies were used at the lowest concentrations which pro-
vided sufficient fluorescent signals (0.05 μ g/ml anti-MHCII-eFluor450, 0.025 μ g/ml anti-CD11c-A488, 0.25 μ g/ml 
anti-SiglecH-A647 0.05 μ g/ml anti-CCR9-PE). During imaging, culture medium was not replenished and no 
additional antibodies or Flt3L were added. Time-lapse imaging was performed with a cell observer system (Zeiss, 
Oberkochen, Germany) at constant 37 °C and 5% CO2. Bright field images were taken at 2 min intervals while 
fluorescent images were taken at 3–4 h intervals with an Axiocam-HRm camera (1338 × 1040 pixel resolution) 
with 10X objective. Carl Zeiss AxioVision 4.5 Software was used in this study.
Single cell tracking and analysis of cell fates in pedigrees. Single cell tracking was performed using 
tracking software (TTT50). The software allows loading of acquired phase contrast and fluorescence images with 
determined intervals. Individual cells were tracked and properties such as lost events, cell death, division, and 
fluorescent signals were logged manually by the researchers. All relevant information saved during tracking was 
annotated in pedigrees including fluorescent markers (off, on or high). The raw data consisted of 72 trees originat-
ing from single CDP cells. In 32 out of 72 cases (44%), CDP colonies were lost early in the CDP or pre-DC stage, 
because they could not be tracked further or underwent apoptosis. These colonies were excluded from further 
analysis. Cell fates were assigned to CDP colonies by visual analysis of annotated pedigrees (results shown in 
Fig. 5E). Cell types were identified by predefined marker combinations. If a pDC or cDC phenotype was observed 
in the pedigree, it was assigned a pDC or cDC cell fate. If a SiglecH+ CCR9low phenotype was observed in a ped-
igree without upregulation of CCR9 it was assigned a SiglecH+ CCR9low phenotype. If no marker or only CD11c 
or CCR9 were expressed in a pedigree it was assigned an undifferentiated cell fate.
Statistical analysis. Single cell imaging data was further analysed using self-written statistical software 
(D-BSSE, Basel, Switzerland) and Matlab. Two-group comparisons of normally distributed variables were per-
formed by an unpaired two-sided t-test. Alternatively, data which did not follow a normal distribution or showed 
unequal group variances, was analysed using the non-parametric Kruskal-Wallis test followed by Dunn’s multiple 
comparison test (GraphPad Prism). P values below 0.05 were considered statistically significant. Data are shown 
as box and whisker plots indicating median, interquartile range and outliers. Time to event was calculated as a 
weighted mean = ∑ ⋅ ∑− −w t b( ) 2 / 2b
d b
b
d b( ) ( ), where the sum is taken over cells b at which the event occurs for 
the first time, t(b) is the time until the event occurred in cell b, and d(b) is the depth at which the event occurred, 
i.e., the number of cell divisions preceding the event in the respective branch. Transitions between cell pheno-
types, were counted at all time points and depicted in a transition graph where the width of the connecting arrows 
indicates the number of transitions. The transition time between cell types was calculated as the time between the 
respective events (marker combinations) in the genealogy tree. The whole tree was taken into account. If a marker 
combination was kept over several generations, the transition time for every single cell was calculated.
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